The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for disease‐associated changes
Abstract
Abnormalities of the anterior cingulate cortex have previously been described in schizophrenia, major depressive disorder and bipolar disorder. In this study 2‐DE was performed followed by mass spectrometric sequencing to identify disease‐specific protein changes within the anterior cingulate cortex in these psychiatric disorders. The 2‐DE system comprised IPGs 4–7 and 6–9 in the first, IEF dimension and SDS‐PAGE in the second dimension. Resultant protein spots were compared between control and disease groups. Statistical analysis indicated that 35 spots were differentially expressed in one or more groups. Proteins comprising 26 of these spots were identified by mass spectroscopy. These represented 19 distinct proteins; aconitate hydratase, malate dehydrogenase, fructose bisphosphate aldolase A, ATP synthase, succinyl CoA ketoacid transferase, carbonic anhydrase, α‐ and β‐tubulin, dihydropyrimidinase‐related protein‐1 and ‐2, neuronal protein 25, trypsin precursor, glutamate dehydrogenase, glutamine synthetase, sorcin, vacuolar ATPase, creatine kinase, albumin and guanine nucleotide binding protein β subunit. All but three of these proteins have previously been associated with the major psychiatric disorders. These findings provide support for the view that cytoskeletal and mitochondrial dysfunction are important components of the neuropathology of the major psychiatric disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The often-used alternative approach of housekeeping proteins to normalize for loading biases among samples is sometimes problematic as levels of the HKPs change under various physiological, pathological and pharmacological conditions [271, 619-623].”
From Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1 (2021) · cites this paper as [622]
Citations
Cites
Glial reduction in the subgenual prefrontal cortex in mood disorders
Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525
Emerging principles of altered neural circuitry in schizophrenia
Benes, F. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00041-7 · Cited by 513
Research works printed but not linked: 64
- Liddle P. F., 1992, J. R. Soc. Med., 85, 224, 10.1177/014107689208500415 · DOI
- 10.1176/ajp.154.5.682 · DOI
- 10.1016/j.schres.2004.02.025 · DOI
- 10.1017/S003329170003806X · DOI
- 10.1016/S0006-3223(00)00962-8 · DOI
- 10.1001/archpsyc.56.6.537 · DOI · Paper page
- Hirayasu Y., 1999, Am. J. Psychiatry, 156, 1091, 10.1176/ajp.156.7.1091 · DOI · Paper page
- 10.1176/appi.ajp.158.2.234 · DOI
- 10.1016/j.biopsych.2003.10.017 · DOI · Paper page
- 10.1176/appi.ajp.161.1.99 · DOI
- 10.1001/archpsyc.58.6.545 · DOI · Paper page
- 10.1016/S0006-3223(03)00114-8 · DOI
- 10.1001/archpsyc.1995.03950240033007 · DOI
- 10.1001/archpsyc.1991.01810350036005 · DOI
- 10.1016/S0006-3223(01)01084-8 · DOI · Paper page
- 10.1016/S0006-3223(01)01243-4 · DOI
- 10.1016/S0306-4522(96)00489-7 · DOI
- 10.1016/S0361-9230(01)00530-5 · DOI
- 10.1038/sj.mp.4001511 · DOI
- 10.1038/sj.mp.4000696 · DOI · Paper page
- 10.1016/S0920-9964(99)00192-9 · DOI
- 10.1002/1615-9861(200111)1:11<1405::AID-PROT1405>3.0.CO;2-H · DOI
- 10.1016/0003-2697(76)90527-3 · DOI · Paper page
- 10.1002/pmic.200300624 · DOI
- 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6 · DOI
- 10.1002/1522-2683(200108)22:14<3043::AID-ELPS3043>3.0.CO;2-M · DOI
- 10.1002/elps.200305614 · DOI
- 10.1002/pmic.200300534 · DOI
- 10.1523/JNEUROSCI.22-07-02718.2002 · DOI
- 10.1016/S0920-9964(03)00151-8 · DOI
- 10.1093/hmg/ddi022 · DOI
- 10.1002/ajmg.b.20132 · DOI
- 10.1046/j.1351-5101.2003.00728.x · DOI
- 10.1016/j.biopha.2003.11.004 · DOI
- 10.1002/jnr.20563 · DOI
- 10.1016/j.neulet.2004.12.079 · DOI
- 10.1038/sj.mp.4000580 · DOI
- 10.1016/S0006-3223(02)01729-8 · DOI
- 10.1385/MN:28:1:51 · DOI
- 10.1038/sj.mp.4001233 · DOI
- 10.1038/ncb825 · DOI
- Weitzdoerfer R., 2001, J. Neural Transm. Suppl., 61, 95
- 10.1016/S0301-0082(03)00036-4 · DOI
- 10.1016/j.cell.2004.11.012 · DOI
- 10.1016/S0304-3940(01)01688-3 · DOI
- 10.1002/pmic.200300822 · DOI
- 10.1038/sj.npp.1300112 · DOI
- 10.1002/pmic.200300535 · DOI
- 10.1016/S0960-894X(03)00507-9 · DOI
- 10.1016/0006-2952(90)90196-R · DOI
- 10.1016/S0024-3205(02)02107-0 · DOI
- 10.1002/jnr.490280304 · DOI
- 10.1046/j.1471-4159.2002.01263.x · DOI
- 10.1016/j.biopsych.2003.12.012 · DOI
- 10.1034/j.1399-5618.2000.020305.x · DOI
- 10.1001/archpsyc.61.3.300 · DOI
- 10.1093/brain/122.4.593 · DOI · Paper page
- 10.1093/brain/awf149 · DOI
- 10.1016/S0006-3223(00)00978-1 · DOI
- Burbaeva G. S., 2003, Biol. Psychiatry, 27, 675
- 10.1080/15622970310029916 · DOI
- 10.1007/BF03161065 · DOI
- 10.1038/sj.tpj.6500217 · DOI
- 10.1097/00001756-200006260-00018 · DOI
Cited by
Sorted by citations
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Autophagy · doi:10.1080/15548627.2015.1100356 · Cited by 5,894
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1
Klionsky, D. J., Abdel-Aziz, A. K., Abdelfatah, S., Abdellatif, M., Abdoli, A., Abel, S., Abeliovich, H., Abildgaard, M. H., Abudu, Y. P., Acevedo-Arozena, A., et al. (2021) · Autophagy · doi:10.1080/15548627.2020.1797280 · Cited by 2,897
Leonard, B., & Maes, M. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.12.005 · Cited by 805
Gardner, A., & Boles, R. G. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.030 · Cited by 333
Maes, M., Fišar, Z., Medina, M., Scapagnini, G., Nowak, G., & Berk, M. (2012) · Inflammopharmacology · doi:10.1007/s10787-011-0111-7 · Cited by 325
Pennington, K., Beasley, C. L., Dicker, P., Fagan, A., English, J., Pariante, C. M., Wait, R., Dunn, M. J., & Cotter, D. R. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002098 · Cited by 227
Self-citationGlial and glutamatergic markers in depression, alcoholism, and their comorbidity
Miguel-Hidalgo, J. J., Waltzer, R., Whittom, A. A., Austin, M. C., Rajkowska, G., & Stockmeier, C. A. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.06.003 · Cited by 218
Le‐Niculescu, H., Patel, S. D., Bhat, M., Kuczenski, R., Faraone, S. V., Tsuang, M. T., McMahon, F. J., Schork, N. J., Nurnberger, J. I., & Niculescu, A. B. (2009) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30887 · Cited by 201
Zuccoli, G. S., Saia-Cereda, V. M., Nascimento, J. M., & Martins-de-Souza, D. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00493 · Cited by 157
Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness
Che, Y., Wang, J.-F., Shao, L., & Young, L. T. (2010) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.090083 · Cited by 155
Martins-de-Souza, D., Harris, L. W., Guest, P. C., & Bahn, S. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3459 · Cited by 134
MahmoudianDehkordi, S., Ahmed, A. T., Bhattacharyya, S., Han, X., Baillie, R. A., Arnold, M., Skime, M. K., John-Williams, L. S., Moseley, M. A., Thompson, J. W., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-020-01097-6 · Cited by 95
Hashimoto, K., Bruno, D., Nierenberg, J., Marmar, C. R., Zetterberg, H., Blennow, K., & Pomara, N. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.8 · Cited by 90
Kahl, K. G., Stapel, B., & Frieling, H. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.09.004 · Cited by 47
Knapman, A., Kaltwasser, S. F., Martins‐de‐Souza, D., Holsboer, F., Landgraf, R., Turck, C. W., Czisch, M., & Touma, C. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07968.x · Cited by 44
PI3K/AKT/GSK3β/CRMP-2-mediated neuroplasticity in depression induced by stress
Wu, Z., Wang, G., Wei, Y., Xiao, L., & Wang, H. (2018) · Neuroreport · doi:10.1097/wnr.0000000000001096 · Cited by 44
Acetyl-L-carnitine and α-lipoic acid: possible neurotherapeutic agents for mood disorders?
Soczynska, J. K., Kennedy, S. H., Chow, C. S., Woldeyohannes, H. O., Konarski, J. Z., & McIntyre, R. S. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.6.827 · Cited by 23
Perić, I., Costina, V., Gass, P., Findeisen, P., & Filipović, D. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.11.013 · Cited by 18
Metadata
- Authors
- Beasley, C. L., Pennington, K., Behan, A., Wait, R., Dunn, M. J., & Cotter, D.
- Venue
- PROTEOMICS
- Publisher
- Wiley
- Published
- 2006-05-24
- Volume
- 6
- Issue
- 11
- Pages
- 3414-3425
- ISSN
- 1615-9853
- 1615-9861
- Cited by
- 263
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review